219 results
Therapeutic Indications for the Anticonvulsant Agents

#Anticonvulsant #Antiseizure #Medications #Pharmacology #Table #Neurology #Epilepsy #Management
#Medications #Pharmacology ... #Table #Neurology ... #Epilepsy #Management
Considerations for Crystalloids - 0.9% NS vs LR vs Plasma-Lyte
 - Causes hyperkalemia?
 - Safe to
Plasma-Lyte - Causes ... - Causes lactic ... - Can cause a NAGMA ... removed- trials were negative ... #Crystalloids #pharmacology
#mnemonic #pharmacology #medications #management  #nephrology
#mnemonic #pharmacology ... #medications #management ... #nephrology
NOAC / DOAC Pharmacology and Prescribing Cheat Sheet
Novel (or Direct) Oral Anti-Coagulants
 • Rivaroxaban
 • Apixaban
NOAC / DOAC Pharmacology ... #NOAC #DOAC #Pharmacology ... #Prescribing #hematology ... #management #Direct
Table of Antibiotics for Highly Resistant Gram Negative Infections 

Ceftazidime, Cefepime, Piperacillin/ Tazobactam, Carbapenems, Aztreonam, Aminoglycosides
Resistant Gram Negative ... Infections #Table #Pharmacology ... #Coverage #Management
HINTS Exam - Unidirectional Nystagmus - Left-beating

In a patient with vertigo symptoms, this finding is reassuring
for a PERIPHERAL cause ... Clinical #Video #Negative ... #Neurology #Peripheral
Diagnosis and Management of Hypernatremia

#Hypernatremia #Differential #Algorithm #Causes #Nephrology #Diagnosis

** GrepMed Recommended Text: Nephrology Secrets -
Diagnosis and Management ... Differential #Algorithm #Causes ... #Nephrology #Diagnosis ... Recommended Text: Nephrology
Conversion - Epoetin alfa (Procrit®) to Darbepoetin alfa (Aranesp™)

#Epoetin #Darbepoetin #Erythropoietin #Conversion #Table #ESAs #Procrit #Aranesp
Procrit #Aranesp #Pharmacology ... #Hematology #Nephrology
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
suspected) • In case ... • Special cases ... Measurement #SLE #rheumatology ... #pharmacology # ... levels #lupus #management
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... Positive in 60-80% of cases ... pANCA anti-MPO - Negative ... Usual therapeutic management ... #Summary #rheumatology